vidarabine

adenine 9-b-D-arabinofuranoside adenine-9-b-D-arabinofuranoside adenine-b-D-arabinofuranoside adenine, 9-b-D-arabinofuranosyl- adenine, 9b-D-arabinofuranosyl- 6- amino-9-b-D-arabinofuranosylpurine (2R,3S,4S,5R)-2-(6- amino-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol (2R,3S,4S,5R)-2-(6- aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol 9-b-D- arabinofuranosyl-9H-purin-6-amine (9CI) 9-b-D- arabinofuranosyl-9H-purine-6-amine 9-b-D- arabinofuranosyladenine 9b-D- arabinofuranosyladenine (+)- cyclaradine spongoadenosine vidarabin vidarabinum PubMed: Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis. PubMed: The pleiotropic flavonoid quercetin: from its metabolism to the inhibition of protein kinases in chronic lymphocytic leukemia. PubMed: Transplant-acquired food allergy (TAFA) following cord blood stem cell transplantation in two adult patients with haematological malignancies. PubMed: 'Reduced malignancy as a mechanism for longevity in mice with adenylyl cyclase type 5 disruption'. PubMed: Drug repurposing for gastrointestinal stromal tumor. PubMed: Rituximab in chronic lymphocytic leukemia. PubMed: U.S. Food and drug administration approval: rituximab in combination with fludarabine and cyclophosphamide for the treatment of patients with chronic lymphocytic leukemia. PubMed: Ofatumumab in the treatment of chronic lymphocytic leukemia. PubMed: Quercetin induced apoptosis in association with death receptors and fludarabine in cells isolated from chronic lymphocytic leukaemia patients. PubMed: U.S. Food and Drug Administration approval: ofatumumab for the treatment of patients with chronic lymphocytic leukemia refractory to fludarabine and alemtuzumab. PubMed: The odyssey of marine pharmaceuticals: a current pipeline perspective. PubMed: Leptin inhibits rosiglitazone-induced adipogenesis in murine primary adipocytes. PubMed: Nelarabine: a new purine analog in the treatment of hematologic malignancies. PubMed: Successful bone marrow transplantation for IPEX syndrome after reduced-intensity conditioning. PubMed: Innovations in antineoplastic therapy. PubMed: The bioavailability of oral fludarabine phosphate is unaffected by food. PubMed: Emerging information on the use of rituximab in chronic lymphocytic leukemia. PubMed: Hemolytic anemia after fludarabine therapy for chronic lymphocytic leukemia. PubMed: Late listeriosis after fludarabine plus prednisone treatment. PubMed: Advances in therapy for hairy cell leukemia. A review. PubMed: From the Food and Drug Administration. PubMed: Fludarabine phosphate: a synthetic purine antimetabolite with significant activity against lymphoid malignancies. PubMed: Purification and characterization of a novel nucleoside phosphorylase from a Klebsiella sp. and its use in the enzymatic production of adenine arabinoside. PubMed: From the Food and Drug Administration. PubMed: [The glomerulopathies of cirrhosis of the liver]. PubMed: Projections on the use of antiviral chemicals in animals. PubMed: Vidarabine approved for herpes simplex virus encephalitis.